Sign in
CompletedNo phase

Guided Fluid-balance Optimization With Mini-fluid chALlenge During Septic Shock

Key facts

Who runs it
University Hospital, Brest
Where
France17 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
535 people enrolled
Started
4 Jun 2019
Ended
8 Jan 2024
Type of study
Interventional, 2 groups
Treatments tested
  • Minifluid challenge
  • Usual practice
Record updated
19 September 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Adult patient (Age > 18 years)
  • Admitted in ICU for less than 3 days
  • Abdominal (excepted urinary tract infection) or pulmonary related septic shock, defined by SEPSIS III criteria diagnosed within less than 12 hours
  • Written consent or oral by the patient (and/or consent signed by the next of skin)
  • Patient has social security affiliation or who beneficiary of such social security

Who cannot take part

  • Cardiac arrest
  • Allergy to albumin
  • Patient with life expectancy inferior to 24 hours at the time of inclusion
  • Pregnancy
  • Traumatic brain injury
  • Limitation of invasive therapeutics, palliative care
  • Patient under guardianship or curatorship

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Many observational studies have highlighted an independent association between fluid overload and clinical outcomes during septic shock. To optimize fluid balance, clinician has several options to consider carefully fluid administration and avoid fluid overload. More than a general restrictive approach, a pragmatic, individual tailored approach should be considered to optimize patients' hemodynamics during acute circulatory failure. Many advances in hemodynamic monitoring were described. Mini-fluid challenge appears to be a sensible method to use for bedside assessment to optimize fluid infusion. The next step for hemodynamic management in the ICU should be to test a hemodynamic goal-directed approach to better control fluid management and eventually improve patient's outcome. The main objective of the GOAL study is to evaluate a pragmatic optimization fluid management protocol tailored to each patient's hemodynamic status based on mini-fluid challenges. This intervention will be compared to usual management based on the latest guidelines. This intervention aims to decrease organ dysfunction during septic shock. This is the first large clinical trial designed to test this hypothesis.

The 2 groups in the trial

  • Minifluid challengeTreatment being tested

    100 ml of 4% Albumin will be deliver to assess fluid responsiveness

  • ControlTreatment being tested

    Patient will be treated as defined by most recent surviving sepsis campaign guidelines

    Treatment: Usual practice

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Guided Fluid-balance Optimization With Mini-fluid chALlenge During Septic Shock: A Multicenter, Stepped Wedge Cluster Randomized Trial
Record updated
19 September 2025